Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond seizures: A multidimensional approach to non-seizure issues in Lennox-Gastaut syndrome. Insights from Italian experts.

Epilepsia open·2026
Same author

An EEG-Based Edge-AI Framework for Alzheimer's and Creutzfeldt-Jakob Disease Classification.

Sensors (Basel, Switzerland)·2026
Same author

Epilepsia partialis continua as the presenting manifestation of Creutzfeldt-Jakob disease: A video-polygraphic clinical vignette.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Effective Surgical Management of Coexisting DNET-Related Focal Epilepsy and Epilepsy with Eyelid Myoclonia.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.

JAMA neurology·2026
Same author

Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.

Epilepsia·2025

Related Experiment Video

Updated: Dec 18, 2025

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

875

Topiramate-induced erectile dysfunction.

Rocco Salvatore Calabrò1, Placido Bramanti, Domenico Italiano

  • 1IRCCS Centro Neurolesi Bonino-Pulejo, S.S.113 via Palermo, Cda Casazza, 98124 Messina, Italy. salbro77@tiscali.it

Epilepsy & Behavior : E&B
|February 5, 2009
PubMed
Summary
This summary is machine-generated.

Topiramate medication can cause temporary erectile dysfunction. Thorough testing ruled out other causes, confirming the drug as the likely culprit.

More Related Videos

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

633
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.9K

Related Experiment Videos

Last Updated: Dec 18, 2025

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

875
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

633
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.9K

Area of Science:

  • Neurology
  • Pharmacology
  • Urology

Background:

  • Erectile dysfunction (ED) is a common condition with multifactorial causes.
  • Topiramate is an anticonvulsant and migraine prophylactic medication with known side effects.

Observation:

  • A case study details a patient experiencing reversible erectile dysfunction.
  • The patient was undergoing treatment with topiramate.

Findings:

  • Comprehensive diagnostic evaluations, including psychological, neurophysiological, ultrasound, and laboratory tests, were performed.
  • These extensive tests excluded other potential causes of erectile dysfunction.
  • The findings strongly suggest topiramate as the cause of the patient's reversible ED.

Implications:

  • This case highlights the importance of considering medication side effects in the differential diagnosis of erectile dysfunction.
  • Clinicians should be aware of topiramate's potential to induce reversible ED.
  • Further research may be warranted to elucidate the precise mechanisms of topiramate-induced erectile dysfunction.